Trilogy International Partners - TRL Stock Forecast, Price & News

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Trilogy International Partners in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" TRL shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TRL, but not buy additional shares or sell existing shares.
View TRL analyst ratings or view top-rated stocks.

1 analysts have issued 1-year target prices for Trilogy International Partners' shares. Their TRL share price forecasts range from C$2.50 to C$2.50. On average, they predict the company's stock price to reach C$2.50 in the next twelve months. This suggests a possible upside of 1,036.4% from the stock's current price.
View analysts price targets for TRL or view top-rated stocks among Wall Street analysts.

Trilogy International Partners' stock was trading at C$2.38 on January 1st, 2022. Since then, TRL shares have decreased by 90.8% and is now trading at C$0.22.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 8th 2022.
View our TRL earnings forecast.

Trilogy International Partners (TSE:TRL) pays an annual dividend of C$1.69 per share and currently has a dividend yield of 845.00%. TRL has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for TRL.

Based on aggregate information from My MarketBeat watchlists, some companies that other Trilogy International Partners investors own include Acerus Pharmaceuticals (ASP), Emera (EMA), Merck & Co., Inc. (MRK), (ONCYF) (ONCYF), AxoGen (AXGN), A and W Revenue Royalties Income Fund (AW.UN), ATS Automation Tooling Systems (ATA), Algonquin Power & Utilities (AQN) and Apptio (APTI).

Trilogy International Partners trades on the Toronto Stock Exchange (TSX) under the ticker symbol "TRL."

Shares of TRL stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

One share of TRL stock can currently be purchased for approximately C$0.22.

Trilogy International Partners (TSE:TRL) has a market capitalization of C$18.88 million and generates C$639.59 million in revenue each year.

The company employs 1,622 workers across the globe.

Trilogy International Partners' mailing address is Bellevue Wa PO Box 1988, BELLEVUE, WA 98009-1988, United States. The specialty pharmaceutical company can be reached via phone at +1-425-4585900.